← Eichor
Study identifier: NCT04676828 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

Condition: Lung Cancer · Radiation-Induced Disorder · Radiation Pneumonitis  ·  Sponsor: University of Aarhus

PhaseNA
Planned participants90
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Study aims to determine if functional lung avoidance based on perfusion single photon emission (SPECT)/CT scan, improves toxicity outcomes for patients with advanced lung cancer undergoing chemo-radiotherapy. Functional avoidance implies a dose plan that takes functional distribution in the lung into account, and avoids highly functional lung volumes sparing them from radiation.

This description comes directly from the study's public registry record.

Talk to the study team

Katherina Farr, MD PhD FRACP  ·  +61 412695410  ·  Katherina.Farr@health.nsw.gov.au

Always discuss trial participation with your own doctor first.

Locations (2)

Sydney West Radiation Oncology Network Westmead and Blacktown HospitalsSydney, New South Wales, AustraliaRecruiting
Department of Oncology, Aarhus University HospitalAarhus, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04676828